What is the debt of Amgen this year?
Amgen has a debt level of 53,669 USD this year.
Amgen Debt 2024
Amgen Debt
53,669 USD
Amgen Dividend yield
3.17 %
Ticker
AMGN
ISIN
US0311621009
WKN
867900
In 2024, Amgen's total debt was 53,669 USD, a 71.38% change from the 31,316 USD total debt recorded in the previous year.
Amgen Aktienanalyse
What does Amgen do?
Amgen Inc. is a global biotechnology company focused on the development and production of pharmaceuticals. It was founded in 1980 by William K. Bowes Jr. and George B. Rathmann in Thousand Oaks, California/USA. The founders had the vision to create new treatment options for serious diseases such as cancer, autoimmune diseases, and osteoporosis. Amgen faced difficulties in its early days due to limited financial resources and setbacks in research. However, the company succeeded in developing the first recombinant therapeutic protein drug, Erythropoietin (EPO), and bringing it to the market. Today, Amgen has become one of the largest biotechnology companies in the world with over 24,000 employees worldwide. The company is known for its research and development work in oncology, kidney diseases, blood disorders, inflammation, and bone diseases. Amgen's business model involves investing in research and development to develop new drugs and commercialize them in global markets. The company follows a "biological platform" strategy, focusing on biotechnology products based on proteins and antibodies. Amgen has several product lines, including Biologics, Biosimilars, and Small Molecules. Biologics are protein-based drugs manufactured using living cells. Biosimilars are products that have similar structures to existing biologics. Small Molecules are chemically manufactured drugs. Some of Amgen's most well-known products include Epogen and Aranesp (both Erythropoietin-releasing hormones), Neulasta and Neupogen (both granulocyte colony-stimulating factors), Enbrel (a TNF inhibitor for the treatment of rheumatoid arthritis), Prolia and Xgeva (both Denosumab inhibitors for the treatment of osteoporosis), and Blincyto (a bispecific antibody against cancer). Amgen is also involved in cancer immunotherapy and has a range of medications in its portfolio, including a CAR-T immunotherapy used for certain forms of acute lymphoblastic leukemia (ALL). In addition, Amgen specializes in the development of biosimilars. In 2017, the company introduced six biosimilars to the market, including copies of Enbrel and Humira for the treatment of rheumatoid arthritis. Biosimilars have the potential to reduce the costs of patient treatment as they are typically cheaper than the original products. Furthermore, Amgen works closely with other companies and research institutions to develop innovative products and technologies. The company has numerous partnerships and licensing agreements with other companies in the biotech industry to accelerate its growth and expand its product pipeline. Overall, Amgen has successfully established itself as one of the leading biotechnology companies in the world. It is known for its innovative products, investments in research and development, and partnerships with other companies. With its wide product portfolio and commitment to producing high-quality biological products, Amgen will continue to play an important role in the healthcare industry. Amgen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Amgen revenue by segment
In the annual report of the Amgen share (US0311621009, 867900, AMGN), it breaks down its revenues into 2 segments: 1. Human Therapeutics, 2. Other. The Amgen stock (WKN: 867900, ISIN: US0311621009, Ticker Symbol: AMGN) is a leading investment for investors interested in participating in the Health Care sector.
Debt Details
Understanding Amgen's Debt Structure
Amgen's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Amgen's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Amgen’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Amgen’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Amgen Stock
What was the debt of Amgen compared to the previous year?
The debt of Amgen has increased by 71.38% compared to the previous year increased.
What are the consequences of high debt for investors in Amgen?
High debt can pose a risk for investors of Amgen, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Amgen?
Low debt means that Amgen has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Amgen affect the company?
An increase in debt of Amgen can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Amgen affect the company?
A reduction in debt of Amgen can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Amgen?
Some factors that can influence the debt of Amgen include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Amgen so important for investors?
The debts of Amgen are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Amgen take to change the debt?
To change the debt, Amgen can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Amgen pay?
Over the past 12 months, Amgen paid a dividend of 8.52 USD . This corresponds to a dividend yield of about 3.17 %. For the coming 12 months, Amgen is expected to pay a dividend of 14.1 USD.
What is the dividend yield of Amgen?
The current dividend yield of Amgen is 3.17 %.
When does Amgen pay dividends?
Amgen pays a quarterly dividend. This is distributed in the months of September, December, March, June.
How secure is the dividend of Amgen?
Amgen paid dividends every year for the past 19 years.
What is the dividend of Amgen?
For the upcoming 12 months, dividends amounting to 14.1 USD are expected. This corresponds to a dividend yield of 5.24 %.
In which sector is Amgen located?
Amgen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Amgen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Amgen from 6/7/2024 amounting to 2.25 USD, you needed to have the stock in your portfolio before the ex-date on 5/16/2024.
When did Amgen pay the last dividend?
The last dividend was paid out on 6/7/2024.
What was the dividend of Amgen in the year 2023?
In the year 2023, Amgen distributed 7.76 USD as dividends.
In which currency does Amgen pay out the dividend?
The dividends of Amgen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Amgen stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Amgen
Our stock analysis for Amgen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amgen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
